125 related articles for article (PubMed ID: 3210258)
21. Effect of cisapride on the gastrointestinal transit of a solid meal in normal human subjects.
Edwards CA; Holden S; Brown C; Read NW
Gut; 1987 Jan; 28(1):13-6. PubMed ID: 3817579
[TBL] [Abstract][Full Text] [Related]
22. Synergistic and antagonistic pharmacodynamic interaction between ranitidine and cisapride: a study on the isolated rabbit intestine.
Koutsoviti-Papadopoulou M; Nikolaidis E; Batzias GC; Kounenis G
Pharmacol Res; 2001 Apr; 43(4):329-34. PubMed ID: 11352537
[TBL] [Abstract][Full Text] [Related]
23. In vitro evaluation of the effect of the opioid antagonist N-methylnaltrexone on motility of the equine jejunum and pelvic flexure.
van Hoogmoed LM; Boscan PL
Equine Vet J; 2005 Jul; 37(4):325-8. PubMed ID: 16028621
[TBL] [Abstract][Full Text] [Related]
24. A comparative study of the effects of four motor-stimulating agents on canine jejunal spike bursts. The use of a computer program to analyze spike burst spread.
Summers RW; Flatt AJ
Scand J Gastroenterol; 1988 Dec; 23(10):1173-81. PubMed ID: 3249915
[TBL] [Abstract][Full Text] [Related]
25. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS
Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
[TBL] [Abstract][Full Text] [Related]
26. Impedance monitoring of equine intestinal motility.
Lamar CH; Masty J; Adams SB; Tacker WA
Am J Vet Res; 1984 Apr; 45(4):810-2. PubMed ID: 6731998
[TBL] [Abstract][Full Text] [Related]
27. The effects of cisapride on the restoration of gut motility after surgery of the small intestine in horses; a clinical trial.
van der Velden MA; Klein WR
Vet Q; 1993 Dec; 15(4):175-9. PubMed ID: 8122356
[TBL] [Abstract][Full Text] [Related]
28. Motility of the distal portion of the jejunum and pelvic flexure in ponies: effects of six drugs.
Adams SB; Lamar CH; Masty J
Am J Vet Res; 1984 Apr; 45(4):795-9. PubMed ID: 6731996
[TBL] [Abstract][Full Text] [Related]
29. Effects of oral cisapride on small bowel motility in irritable bowel syndrome.
Evans PR; Bak YT; Kellow JE
Aliment Pharmacol Ther; 1997 Oct; 11(5):837-44. PubMed ID: 9354190
[TBL] [Abstract][Full Text] [Related]
30. Colon motility and colo-anal reflexes in chronic idiopathic constipation. Effects of a novel enterokinetic agent cisapride.
Reboa G; Arnulfo G; Frascio M; Di Somma C; Pitto G; Berti-Riboli E
Eur J Clin Pharmacol; 1984; 26(6):745-8. PubMed ID: 6489414
[TBL] [Abstract][Full Text] [Related]
31. Cisapride induces clustered spikes and irregular spiking of the small intestine of the rat.
Lördal M; Hellström PM; Johansson C
Scand J Gastroenterol Suppl; 1988; 152():48-53. PubMed ID: 2908190
[TBL] [Abstract][Full Text] [Related]
32. Antagonism of endotoxin-induced disruption of equine gastrointestinal motility with the platelet-activating factor antagonist WEB 2086.
King JN; Gerring EL
J Vet Pharmacol Ther; 1990 Dec; 13(4):333-9. PubMed ID: 2287025
[TBL] [Abstract][Full Text] [Related]
33. Effect of cisapride on the cholinergic control mechanisms of gastrointestinal motility in dogs.
Fujii K; Okajima M; Kawahori K
Nihon Heikatsukin Gakkai Zasshi; 1988 Jan; 24(1):1-12. PubMed ID: 3386083
[TBL] [Abstract][Full Text] [Related]
34. Effect of cisapride and renzapride on gastrointestinal motility and plasma motilin concentration in dogs.
Song CW; Lee KY; Kim CD; Chang TM; Chey WY
J Pharmacol Exp Ther; 1997 Jun; 281(3):1312-6. PubMed ID: 9190867
[TBL] [Abstract][Full Text] [Related]
35. AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs.
Yoshida N; Ito T; Karasawa T; Itoh Z
J Pharmacol Exp Ther; 1991 May; 257(2):781-7. PubMed ID: 2033519
[TBL] [Abstract][Full Text] [Related]
36. Cisapride and 5-hydroxytryptamine enhance motility in the canine antrum via separate pathways, not involving 5-hydroxytryptamine1,2,3,4 receptors.
de Ridder WJ; Schuurkes JA
J Pharmacol Exp Ther; 1993 Jan; 264(1):79-88. PubMed ID: 8093733
[TBL] [Abstract][Full Text] [Related]
37. [Development of a new gastrointestinal prokinetic; pharmacology of cisapride].
Van Nueten JM; Schuurkes JA
J Pharm Belg; 1991; 46(1):17-22. PubMed ID: 2051298
[TBL] [Abstract][Full Text] [Related]
38. Human intestinal motor activity and transport: effects of a synthetic opiate.
Kachel G; Ruppin H; Hagel J; Barina W; Meinhardt M; Domschke W
Gastroenterology; 1986 Jan; 90(1):85-93. PubMed ID: 3940260
[TBL] [Abstract][Full Text] [Related]
39. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.
Wiseman LR; Faulds D
Drugs; 1994 Jan; 47(1):116-52. PubMed ID: 7510617
[TBL] [Abstract][Full Text] [Related]
40. The genesis of bowel sounds: influence of viscus and gastrointestinal content.
Politzer JP; Devroede G; Vasseur C; Gerard J; Thibault R
Gastroenterology; 1976 Aug; 71(2):282-5. PubMed ID: 939390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
